A startup broadly referred to as “ChatGPT for medical doctors” raised a brand new funding spherical that values the corporate at $12 billion.
OpenEvidence, primarily based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the corporate advised CNBC. The startup first raised outdoors capital in February, when it reeled in $75 million from Sequoia at a $1 billion valuation, earlier than its worth jumped to $6 billion in October.
In lower than a 12 months, OpenEvidence has raised $700 million from traders together with Google’s enterprise arm, Nvidia, Kleiner Perkins, David Sacks’ Craft Ventures and Mayo Clinic.
The corporate was based in 2022 by Daniel Nadler, who beforehand constructed Kensho Applied sciences, a man-made intelligence firm that was acquired by Customary & Poor’s for about $700 million in 2018, and by Zachary Ziegler, a Harvard PhD pupil in AI. Nadler’s latest enterprise supplies a chatbot for medical doctors, with its AI fashions having been educated on knowledge and knowledge from prime scientific journals, Nadler mentioned in an interview.
“‘ChatGPT for medical doctors’ is a helpful shorthand, however what we actually do is assist physicians make high-stakes scientific selections on the level of care,” Nadler mentioned. “It is not educated on the open web or social media, which may introduce low-quality medical info.”
Nadler claimed OpenEvidence is probably the most broadly used AI platform by medical doctors within the U.S., with greater than 40% of physicians using the software. He pointed to the large alternative in well being care, which accounts for almost 20% of U.S. gross home product with $5 trillion in annual spending.
“Well being care is the most important section of the true financial system,” Nadler mentioned. “Folks understand there may very well be a whole lot of winners within the area.”
These names might embody OpenAI and Anthropic.
OpenAI launched “ChatGPT Well being” earlier this month, whereas Anthropic has “Claude Healthcare.” Each are Well being Insurance coverage Portability and Accountability Act, or HIPAA, compliant extensions of their in style client chatbots.
Whereas competitors is rising, Nadler mentioned his firm’s moat is its give attention to physicians, high quality of information and a first-mover benefit.
“We have already gathered lots of of tens of millions of real-world scientific consultations from verified physicians — that suggestions loop is extremely onerous to copy,” Nadler mentioned. “Even when somebody copied the playbook right now, they’d nonetheless be far behind as a result of it is not simply the partnerships, it is the real-world utilization knowledge.”
Counting on promoting
OpenEvidence mentioned it topped $100 million in annualized income final 12 months, principally fueled by natural progress. Nadler mentioned 95% of recent customers hear about OpenEvidence from one other doctor.
“Most well being care in America is not taking place at billion-dollar hospitals in New York or San Francisco,” Nadler mentioned. “It is taking place in small practices that do not have IT departments or budgets for costly software program.”
OpenEvidence was one of many first AI startups to depend on promoting for income, which Nadler mentioned permits sooner adoption and wider use versus a paid subscription mannequin. Firms pays for promotions via video advertisements on the OpenEvidence app.
The unreal intelligence trade has began to heat as much as ad-based income. Final week, OpenAI mentioned it was testing an ad-supported model of ChatGPT. Nadler mentioned he is attempting to be extra disciplined than some firms which are “brazenly planning to burn billions or tens of billions over the following a number of years.”
“That is a giant guess, and a really dangerous guess,” Nadler mentioned, including that OpenEvidence is attempting to steadiness progress with eventual profitability. “We’re not operating this like a non-public fairness portfolio firm, however we’re additionally not planning on burning billions of {dollars} over the following 12 months.”
AI startups are selecting up this 12 months the place they left off in 2025.
Within the third quarter of final 12 months, there have been six AI funding rounds of greater than $1 billion, in accordance with CB Insights. Anthropic is in talks to boost a further $10 billion as of January, whereas Elon Musk’s xAI introduced a $20 billion spherical this month.
Nadler mentioned that with the large tech firms aggressively pursuing acquisitions within the area, he is felt the strain, however has remained set on constructing OpenEvidence as a stand-alone firm.
“I’ve carried out the acquisition route earlier than,” he mentioned. “It may be nice. However this time, I need to construct one thing that compounds over a few years.”
As for an preliminary public providing, he mentioned SpaceX, OpenAI and Anthropic, which have all been rumored to be potential 2026 candidates, have to go public first.
“There’s an order to nature,” Nadler mentioned. “Basis mannequin firms go public first. Then the appliance layer follows. That is how the web performed out, and that is how this cycle will play out, too.”
Correction: A previous model of this story misidentified the corporate’s location.
WATCH: OpenAI investor letter
